One of the potentially interesting targets, linked to mechanisms of chemoresistance in SCLC, is the activation of the hepatocyte growth factor (HGF)/mesenchymal-epithelial transition (MET) receptor tyrosine kinase (RTK) signaling pathway via the induction of the epithelial to mesenchymal transition (EMT). This evidence concerns the gene MET and small cell lung carcinoma.